| pubmed-article:18753741 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0028754 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0034719 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0160420 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0035096 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0543482 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0205245 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0443211 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0728938 | lld:lifeskim |
| pubmed-article:18753741 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:18753741 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18753741 | pubmed:dateCreated | 2009-2-27 | lld:pubmed |
| pubmed-article:18753741 | pubmed:abstractText | In experimental nephropathies, inhibitors of the renin-angiotensin-system (RAS) halted the progression, or even induced a regression in renal injury. We studied the potential of the angiotensin-converting enzyme (ACE) inhibitor perindopril and the angiotensin receptor blocker candesartan to reverse the established renal injury in the obese Zucker rat (OZR). | lld:pubmed |
| pubmed-article:18753741 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18753741 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18753741 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18753741 | pubmed:issn | 1421-9670 | lld:pubmed |
| pubmed-article:18753741 | pubmed:author | pubmed-author:AmannKerstinK | lld:pubmed |
| pubmed-article:18753741 | pubmed:author | pubmed-author:SebekováKatar... | lld:pubmed |
| pubmed-article:18753741 | pubmed:author | pubmed-author:HeidlandAugus... | lld:pubmed |
| pubmed-article:18753741 | pubmed:author | pubmed-author:BoorPeterP | lld:pubmed |
| pubmed-article:18753741 | pubmed:author | pubmed-author:LillMariaM | lld:pubmed |
| pubmed-article:18753741 | pubmed:copyrightInfo | 2008 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:18753741 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18753741 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:18753741 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18753741 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18753741 | pubmed:pagination | 164-70 | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:meshHeading | pubmed-meshheading:18753741... | lld:pubmed |
| pubmed-article:18753741 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18753741 | pubmed:articleTitle | Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. | lld:pubmed |
| pubmed-article:18753741 | pubmed:affiliation | Department of Clinical and Experimental Pharmacotherapy, Slovak Medical University, Bratislava, Slovakia. katarina.sebekova@szu.sk | lld:pubmed |
| pubmed-article:18753741 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18753741 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
